Skip to main content
Premium Trial:

Request an Annual Quote

GenePOC Strep A Test Granted FDA Clearance

NEW YORK (GenomeWeb) – GenePOC announced today that its rapid molecular assay to detect group A Streptococcus has been granted clearance by the US Food and Drug Administration.

The test, which runs on GenePOC's Revogene instrument, is the third test from the Quebec City-based diagnostics developer to be FDA cleared. It uses throat swab samples and can report positive Strep A results in as little as 42 minutes, and negative results in 70 minutes without requirement for confirmation by bacterial culture, the firm said in a statement. 

The company obtained FDA clearance of its Revogene instrument and an assay for group B Strep in 2017, followed by an assay to detect Clostridium difficile. GenePOC is also currently developing small molecular panels for carbapenem-resistant enterobacteriaceae (CRE) and gastrointestinal infections.

"GenePOC is committed to developing important assays to complete its current offering, becoming a strong player in the field of rapid molecular diagnostics," CEO Patrice Allibert said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.